5,081 Shares in Invesco Bloomberg Analyst Rating Improvers ETF (NYSEARCA:UPGD) Bought by Morey & Quinn Wealth Partners LLC

Morey & Quinn Wealth Partners LLC acquired a new stake in shares of Invesco Bloomberg Analyst Rating Improvers ETF (NYSEARCA:UPGD) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 5,081 shares of the company’s stock, valued at approximately $351,000. Morey & Quinn Wealth Partners LLC owned about 0.30% of Invesco Bloomberg Analyst Rating Improvers ETF at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in UPGD. FMR LLC acquired a new stake in shares of Invesco Bloomberg Analyst Rating Improvers ETF in the 3rd quarter valued at about $58,000. Flow Traders U.S. LLC acquired a new stake in Invesco Bloomberg Analyst Rating Improvers ETF during the third quarter valued at approximately $337,000. Sunbelt Securities Inc. acquired a new stake in Invesco Bloomberg Analyst Rating Improvers ETF during the third quarter valued at approximately $63,000. Raymond James Financial Inc. bought a new position in Invesco Bloomberg Analyst Rating Improvers ETF during the 4th quarter worth approximately $13,460,000. Finally, Millstone Evans Group LLC acquired a new position in shares of Invesco Bloomberg Analyst Rating Improvers ETF in the 4th quarter worth approximately $312,000.

Invesco Bloomberg Analyst Rating Improvers ETF Trading Down 0.3 %

Shares of NYSEARCA UPGD opened at $70.18 on Wednesday. The company has a market capitalization of $106.67 million, a price-to-earnings ratio of 20.48 and a beta of 1.23. Invesco Bloomberg Analyst Rating Improvers ETF has a twelve month low of $62.74 and a twelve month high of $75.85. The business has a 50 day simple moving average of $71.26 and a 200-day simple moving average of $71.52.

About Invesco Bloomberg Analyst Rating Improvers ETF

The Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) is an exchange-traded fund that is based on the Bloomberg ANR Improvers index. The fund tracks an equal-weighted index of large-and mid-cap US stocks that are identified to have the most improved consensus ratings based on analyst recommendations.